The aim of the mentoring is to increase the impact and patient benefit of the excellent science funded in EJP RD. With this mentoring support, applicants will receive project-specific feedback from a panel of drug development, biomarker validation, methodological and regulatory experts tasked with optimizing the translational feasibility of the study. There are no costs or obligations to you.
View this resource Bookmark this resourceConsulting & Advice
Sources of mentoring services
Expert Mentoring Service Information Sheet
Published by EATRIS
Project ManagementEATRISTranslational Medicine supportAdvancing promising technologies and therapies towards clinical application is a complex undertaking. Academic research often lacks easy access to regulatory, therapy development expertise, manufacturing, and healthcare practice, leading to high failure rates. For this reason, the European Joint Programme on Rare Diseases (EJP RD) has initiated a mentoring programme for rare disease researchers. The aim of the mentoring is to increase the impact and patient benefit of the excellent science funded in EJP RD. With this mentoring support, applicants will receive project-specific feedback from a panel of drug development, biomarker validation, methodological and regulatory experts tasked with optimizing the translational feasibility of the study.
View this resource Bookmark this resource
TREAT-NMD Advisory Committee for Therapeutics
Published by IRDiRC
Advisory Committee for TherapeuticsTREAT-NMDEstablished in 2009, the TREAT-NMD Advisory Committee for Therapeutics (TACT) is a unique multi-disciplinary international group of internationally recognized academic and industry drug development experts as well as representatives of patient foundations and regulatory experts
View this resource Bookmark this resource
EATRIS Translational assessment services
Published by n/a
Project ManagementEATRISTranslational Medicine supportEATRIS supports your investigators in assessing and optimising the translational feasibility and potential of the projects that your are interested in funding. By providing feedback to you and the investigator on issues such as medical need, market and pipeline overview, regulatory pathway, intellectual property and translational tools, you have more confidence in selecting high potential projects, and investigators can optimise their plans according the realities of the development pipeline.
View this resource Bookmark this resource